As PD-1 or TIM-3 are co-expressed by TIGIT-positive T cells, targeting TIGIT could be an additional mechanism to avert exhaustion of T cells in B-cell Non-Hodgkin Lymphoma (B-NHL) (155). The gene discussed is TIGIT; the disease is B-cell non-Hodgkin lymphoma.